These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 3121842
1. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. Duncan GE, Criswell HE, McCown TJ, Paul IA, Mueller RA, Breese GR. J Pharmacol Exp Ther; 1987 Dec; 243(3):1027-34. PubMed ID: 3121842 [Abstract] [Full Text] [Related]
2. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA. J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [Abstract] [Full Text] [Related]
3. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. Breese GR, Napier TC, Mueller RA. J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987 [Abstract] [Full Text] [Related]
4. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors. Breese GR, Criswell HE, McQuade RD, Iorio LC, Mueller RA. J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972 [Abstract] [Full Text] [Related]
5. Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain. Lappalainen J, Hietala J, Koulu M, Seppälä T, Sjöholm B, Syvälahti E. J Pharmacol Exp Ther; 1990 Feb; 252(2):845-52. PubMed ID: 2179533 [Abstract] [Full Text] [Related]
6. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. Criswell HE, Johnson KB, Mueller RA, Breese GR. J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756 [Abstract] [Full Text] [Related]
11. Assessment of purine-dopamine interactions in 6-hydroxydopamine-lesioned rats: evidence for pre- and postsynaptic influences by adenosine. Criswell H, Mueller RA, Breese GR. J Pharmacol Exp Ther; 1988 Feb; 244(2):493-500. PubMed ID: 3126293 [Abstract] [Full Text] [Related]
12. Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. Criswell H, Mueller RA, Breese GR. J Neurosci; 1989 Jan; 9(1):125-33. PubMed ID: 2521511 [Abstract] [Full Text] [Related]
13. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain. Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J, Andersson K, von Euler G. Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740 [Abstract] [Full Text] [Related]